Shanghai No.1 Pharmacy Co., Ltd. (600833.SS)
CNY 14.58
(-4.33%)
CNY 14.58
(-4.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 186.51 Million CNY | -76.92% |
| 2022 | 258.58 Million CNY | 159.42% |
| 2021 | 119.49 Million CNY | 7.65% |
| 2020 | 106.64 Million CNY | 29.35% |
| 2019 | 85.97 Million CNY | 678.24% |
| 2018 | 21.85 Million CNY | -124.03% |
| 2017 | 59.06 Million CNY | 14.42% |
| 2016 | 51.53 Million CNY | 3.95% |
| 2015 | 49.44 Million CNY | -14.2% |
| 2014 | 53.11 Million CNY | 17.88% |
| 2013 | 49.09 Million CNY | -21.02% |
| 2012 | 61.87 Million CNY | 0.08% |
| 2011 | 61.14 Million CNY | 19.49% |
| 2010 | 50.42 Million CNY | -19.69% |
| 2009 | 64.13 Million CNY | 64.85% |
| 2008 | 39.26 Million CNY | -10.74% |
| 2007 | 43.48 Million CNY | 36.01% |
| 2006 | 38.9 Million CNY | -2.05% |
| 2005 | 33.04 Million CNY | 2.91% |
| 2004 | 32.1 Million CNY | 21.75% |
| 2003 | 26.35 Million CNY | -8.08% |
| 2002 | 28.66 Million CNY | -18.6% |
| 2001 | 33.26 Million CNY | 168.56% |
| 2000 | -93.01 Million CNY | -93.05% |
| 1999 | -26.6 Million CNY | 18.75% |
| 1998 | -41.6 Million CNY | -150.53% |
| 1997 | -21.26 Million CNY | 0.18% |
| 1996 | 64.69 Million CNY | 332.52% |
| 1995 | 14.95 Million CNY | -87.79% |
| 1994 | 122.53 Million CNY | 4945.01% |
| 1993 | -2.52 Million CNY | -176.39% |
| 1992 | -915 Thousand CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 47.99 Million CNY | 10.09% |
| 2024 Q2 | -14.24 Million CNY | 90.1% |
| 2024 Q3 | 24.95 Million CNY | -79.96% |
| 2023 Q1 | 40.55 Million CNY | -70.56% |
| 2023 Q4 | -3.17 Million CNY | -143.75% |
| 2023 Q3 | 7.25 Million CNY | -68.21% |
| 2023 FY | - CNY | -76.92% |
| 2023 Q2 | 22.81 Million CNY | -43.74% |
| 2022 FY | - CNY | 159.42% |
| 2022 Q1 | 8.65 Million CNY | -58.45% |
| 2022 Q2 | 40.08 Million CNY | 362.99% |
| 2022 Q3 | 59.28 Million CNY | 47.88% |
| 2022 Q4 | 137.74 Million CNY | 132.36% |
| 2021 Q3 | 14.36 Million CNY | -22.3% |
| 2021 Q4 | 20.83 Million CNY | 45.03% |
| 2021 Q1 | 15.39 Million CNY | -10.92% |
| 2021 FY | - CNY | 7.65% |
| 2021 Q2 | 18.49 Million CNY | 20.12% |
| 2020 Q4 | 17.28 Million CNY | -48.21% |
| 2020 Q3 | 33.37 Million CNY | 84.98% |
| 2020 Q2 | 18.04 Million CNY | -38.02% |
| 2020 Q1 | 29.1 Million CNY | -31.36% |
| 2020 FY | - CNY | 29.35% |
| 2019 Q4 | 42.4 Million CNY | 353.25% |
| 2019 Q3 | 9.35 Million CNY | 60.24% |
| 2019 Q1 | 15.14 Million CNY | 132.26% |
| 2019 Q2 | 5.83 Million CNY | -61.45% |
| 2019 FY | - CNY | 678.24% |
| 2018 Q2 | 2.3 Million CNY | -81.45% |
| 2018 FY | - CNY | -124.03% |
| 2018 Q1 | 12.44 Million CNY | 14.9% |
| 2018 Q4 | -46.94 Million CNY | -548.28% |
| 2018 Q3 | 10.47 Million CNY | 353.58% |
| 2017 Q4 | 10.83 Million CNY | 45.4% |
| 2017 Q3 | 7.44 Million CNY | -52.46% |
| 2017 FY | - CNY | 14.42% |
| 2017 Q2 | 15.66 Million CNY | -2.66% |
| 2017 Q1 | 16.09 Million CNY | 390.36% |
| 2016 Q2 | 12.85 Million CNY | -12.28% |
| 2016 FY | - CNY | 3.95% |
| 2016 Q1 | 14.65 Million CNY | 53.07% |
| 2016 Q3 | 11.85 Million CNY | -7.79% |
| 2016 Q4 | 3.28 Million CNY | -72.31% |
| 2015 Q3 | 9.6 Million CNY | 22.13% |
| 2015 Q2 | 7.86 Million CNY | -41.64% |
| 2015 Q1 | 13.47 Million CNY | -12.58% |
| 2015 FY | - CNY | -14.2% |
| 2015 Q4 | 9.57 Million CNY | -0.29% |
| 2014 Q3 | 10.38 Million CNY | 34.67% |
| 2014 Q2 | 7.71 Million CNY | -41.04% |
| 2014 Q1 | 13.07 Million CNY | 52.69% |
| 2014 Q4 | 15.41 Million CNY | 48.4% |
| 2014 FY | - CNY | 17.88% |
| 2013 Q2 | 8.89 Million CNY | -32.12% |
| 2013 FY | - CNY | -21.02% |
| 2013 Q4 | 8.56 Million CNY | -6.29% |
| 2013 Q3 | 9.14 Million CNY | 2.79% |
| 2013 Q1 | 13.1 Million CNY | -23.9% |
| 2012 Q2 | 9.77 Million CNY | -28.39% |
| 2012 Q4 | 17.21 Million CNY | 60.07% |
| 2012 FY | - CNY | 0.08% |
| 2012 Q1 | 13.65 Million CNY | -28.03% |
| 2012 Q3 | 10.75 Million CNY | 10.0% |
| 2011 Q1 | 12.47 Million CNY | 5.73% |
| 2011 Q4 | 18.97 Million CNY | 113.05% |
| 2011 FY | - CNY | 19.49% |
| 2011 Q2 | 12.5 Million CNY | 0.27% |
| 2011 Q3 | 8.9 Million CNY | -28.81% |
| 2010 Q3 | 8.08 Million CNY | -24.26% |
| 2010 FY | - CNY | -19.69% |
| 2010 Q2 | 10.67 Million CNY | -4.36% |
| 2010 Q1 | 11.16 Million CNY | -63.57% |
| 2010 Q4 | 11.79 Million CNY | 45.9% |
| 2009 Q1 | 8.51 Million CNY | 9.09% |
| 2009 Q3 | 6.11 Million CNY | -78.1% |
| 2009 Q2 | 27.91 Million CNY | 227.96% |
| 2009 FY | - CNY | 64.85% |
| 2009 Q4 | 30.64 Million CNY | 401.27% |
| 2008 Q2 | 6 Million CNY | -18.47% |
| 2008 Q4 | 7.8 Million CNY | 54.12% |
| 2008 Q3 | 5.06 Million CNY | -15.72% |
| 2008 Q1 | 7.36 Million CNY | -13.39% |
| 2008 FY | - CNY | -10.74% |
| 2007 FY | - CNY | 36.01% |
| 2007 Q2 | 10.99 Million CNY | -1.7% |
| 2007 Q3 | 6.22 Million CNY | -43.35% |
| 2007 Q4 | 8.5 Million CNY | 36.59% |
| 2007 Q1 | 11.18 Million CNY | -46.18% |
| 2006 FY | - CNY | -2.05% |
| 2006 Q1 | 3.38 Million CNY | -84.27% |
| 2006 Q2 | 10.74 Million CNY | 217.62% |
| 2006 Q3 | 5.07 Million CNY | -52.74% |
| 2006 Q4 | 20.78 Million CNY | 309.16% |
| 2005 Q4 | 21.5 Million CNY | 516.06% |
| 2005 Q2 | 12.22 Million CNY | 181.22% |
| 2005 Q3 | 3.49 Million CNY | -71.45% |
| 2005 Q1 | 4.34 Million CNY | -78.06% |
| 2005 FY | - CNY | 2.91% |
| 2004 Q1 | 5.55 Million CNY | -63.08% |
| 2004 Q4 | 19.81 Million CNY | 431.86% |
| 2004 FY | - CNY | 21.75% |
| 2004 Q2 | 10.33 Million CNY | 85.94% |
| 2004 Q3 | 3.72 Million CNY | -63.95% |
| 2003 FY | - CNY | -8.08% |
| 2003 Q2 | 8.31 Million CNY | 81.35% |
| 2003 Q1 | 4.58 Million CNY | -74.77% |
| 2003 Q4 | 15.05 Million CNY | 488.86% |
| 2003 Q3 | 2.55 Million CNY | -69.25% |
| 2002 FY | - CNY | -18.6% |
| 2002 Q4 | 18.16 Million CNY | 359.68% |
| 2002 Q3 | -6.99 Million CNY | -206.13% |
| 2002 Q2 | 6.59 Million CNY | 210.44% |
| 2002 Q1 | 2.12 Million CNY | -93.03% |
| 2001 Q3 | -7.9 Million CNY | 0.0% |
| 2001 Q4 | 30.46 Million CNY | 485.29% |
| 2001 FY | - CNY | 168.56% |
| 2000 FY | - CNY | -93.05% |
| 1999 FY | - CNY | 18.75% |
| 1998 FY | - CNY | -150.53% |
| 1997 FY | - CNY | 0.18% |
| 1996 FY | - CNY | 332.52% |
| 1995 FY | - CNY | -87.79% |
| 1994 FY | - CNY | 4945.01% |
| 1993 FY | - CNY | -176.39% |
| 1992 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jointown Pharmaceutical Group Co., Ltd | 5.08 Billion CNY | 96.331% |
| LBX Pharmacy Chain Joint Stock Company | 3.06 Billion CNY | 93.924% |
| Yifeng Pharmacy Chain Co., Ltd. | 4.04 Billion CNY | 95.393% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 1.53 Billion CNY | 87.881% |